KVUEKenvue

SPX

Data as of Oct 15, 2026 · 09:38 p.m.

$18.00

+1.32%

Unlock full analysis
44/100
▼ Partial Sell Zone

Early deterioration

The canonical InvestCompass profile currently shows several areas that warrant caution.

Global score threshold

Buy Zone ≥ 80
Partial Buy Zone ≥ 65
Neutral Zone ≥ 45
Partial Sell Zone ≥ 25
Sell Zone < 25

Kenvue

KVUE
Market
SPX
Sector:
Consumer Staples
Industry
Household & Personal Products

About the company

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Global score detail

Breakdown of the 4 modules in the global score (Macro, Sector, Fundamental, Technical)

1. Macro(15%)57/100
Sector(30%)36/100
Fundamental(25%)54/100
Technical(30%)38/100
Macro — Full analysis workspace
Fundamental — Full analysis workspace
Sector — Full analysis workspace
Technical — Full analysis workspace
Fundamentals and peer comparison
Signals and trade plan

Current Price

$18.00

Period High

$20.13

Period Low

$14.02

Analyst Target

$19.50

8.4% upside

Price history

Loading chart...

Moving averages
Technical indicators
Technical indicators
Technical indicators
Technical indicators
Moving averages
Technical indicators
AI and news commentary
AI and news commentary

InvestCompass provides analysis tools, not financial advice. Data may be delayed.

KVUE: Kenvue stock analysis | InvestCompass